Company profile: Altesa BioSciences
1.1 - Company Overview
Company description
- Provider of clinical-stage biopharmaceutical research and development focused on accelerating the development of new treatments.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Altesa BioSciences
TriPharm
HQ: United States
Website
- Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriPharm company profile →
ITS Innovation
HQ: United Kingdom
Website
- Description: Provider of synthetic vaccines for mutating viruses using a T-cell vaccine platform that targets conserved viral antigens to direct immune responses, and of pemvidutide, a GLP-1/glucagon dual receptor agonist for obesity and MASH, designed to reduce body weight, liver fat, serum lipids, and address liver fat and fibrosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ITS Innovation company profile →
Discuva
HQ: United Kingdom
Website
- Description: Provider of next-generation antibiotic discovery, Cambridge (UK)-based, established to address major gaps in the treatment of infective disease using proprietary methods, and developer of Ivonescimab (SMT112), a bispecific PD-1/VEGF antibody for oncology in Phase III trials for non-small cell lung cancer and other solid tumors, with over 1,600 patients treated.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Discuva company profile →
Alphyn Biologics
HQ: United States
Website
- Description: Provider of proprietary drug therapies for skin diseases, including Zabalafin hydrogel (AB-101a), a steroid-free topical for atopic dermatitis targeting immune and bacterial components; the Zabalafin (AB-101) multi-bioactive platform; and AB-101b in development for Epidermolysis Bullosa to address inflammation, itch, pain, and skin infection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alphyn Biologics company profile →
Eurocine Vaccines
HQ: United States
Website
- Description: Provider of nasal flu vaccines for children and the elderly, managing preclinical and clinical development, scalability into manufacturing, business development, and funding. Offers Endocine, a nasal vaccine adjuvant used in clinical trials showing safety and tolerability in over 400 human subjects; an HSV-2 therapeutic vaccine candidate; and vaccine development services from conceptualization to commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurocine Vaccines company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Altesa BioSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Altesa BioSciences
2.2 - Growth funds investing in similar companies to Altesa BioSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Altesa BioSciences
4.2 - Public trading comparable groups for Altesa BioSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →